walking motor function study

Valproic acid and carnitine didn't help nonwalkers with SMA who were 2 to 8 years old

posted on February 13, 2009 - 1:31pm
Preliminary results in the phase 2 study of valproic acid and carnitine in children with types 2 and 3 spinal muscular atrophy (SMA) suggest the treatment may have improved function in children younger than age 3 who were not walking at study entry. However, there was no benefit of the drug treatment when a larger group that included children ages 2 to 8 who were not walking was compared with a...

New content is being added every day. Please check back again.